Substandard anti-malarial drugs in Burkina Faso

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Tipke, Maike ^a   Diallo, Salou ^b   Coulibaly, Boubacar ^b   Störzinger, Dominic ^a   Hoppe Tichy, Torsten ^a   Sie, Ali ^b   Müller, Olaf ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CENTRE DE RECHERCHE EN SANTÉ DE NOUNA   (Burkina Faso)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; CHLOROQUINE; FANSIDAR; PYRIMETHAMINE; QUININE; SULFADOXINE; ANTIMALARIAL AGENT;

ARTICLE; BURKINA FASO; DRUG MARKETING; DRUG QUALITY; DRUG SCREENING; DRUG TRAFFIC; HEALTH AUXILIARY; HEALTH CARE FACILITY; MALARIA; PHARMACY; PLASMODIUM FALCIPARUM; QUALITY CONTROL; THIN LAYER CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY; ANIMAL; DRUG EFFECT; DRUG SENSITIVITY; HEALTH SERVICES RESEARCH; HUMAN; STANDARD;

ANIMALS; ANTIMALARIALS; BURKINA FASO; HEALTH SERVICES RESEARCH; HUMANS; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; QUALITY CONTROL;

EID: 44949240746     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-95     Document Type: Article

References (39)

1. Malaria. BM Greenwood K Bojang CJM Whitty GA Targett, Lancet 2005 365 1487 1498 10.1016/S0140-6736(05)66420-3 15850634
2. The great failure of malaria control in Africa: A district perspective from Burkina Faso. B Kouyaté A Sie M Yé M De Allegri O Müller, PLoS Med 2007 4 e127 doi:10.1371/journal.pmed.0040127 17550300 10.1371/journal.pmed.0040127
3. Malaria morbidity, treatment-seeking behaviour, and mortality in a cohort of young children in rural Burkina Faso. O Müller C Traoré H Becher B Kouyaté Trop Med Int Health 2003 8 290 296 10.1046/j.1365-3156.2003. 01030.x 12667146
4. Counterfeit medicines. WHO, Fact sheet 2006 275 http://www.who.int/ mediacentre/factsheets/fs275/en/ Accessed: 17.04.2007
5. Murder by fake drugs. PN Newton NJ White JA Rozendaal MD Green, BMJ 2002 324 800 801 11934760 10.1136/bmj.324.7341.800
6. Influx of fake drugs to Nigeria worries health experts. A Raufu, BMJ 2002 324 698 11909782 10.1136/bmj.324.7339.698
7. The global threat of counterfeit drugs: why industry and government must communicate the danger. R Cockburn PN Newton KE Agyarko D Akunyili NJ Withe, PLoS Med 2005 2 e100 15755195 10.1371/journal.pmed.0020100
8. Pharmaceuticals: Counterfeits, Substandard Drugs and Drug Diversion. The World Bank, HNP brief no 2 Report number 32192 2005
9. Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication. LK Basco, Am J Trop Med Hyg 2004 70 245 250 15031511
10. WHO fights fake pharmaceuticals. K Ahmad, Lancet Infect Dis 2006 6 195 10.1016/S1473-3099(06)70427-3
11. Counterfeit anti-infective drugs. PN Newton MD Green FM Fernández NPJ Day NJ White, Lancet Infect Dis 2006 6 602 613 10.1016/S1473-3099(06)70581-3 16931411
12. Characterization of counterfeit artesunate antimalarial tablets from southeast Asia. KA Hall PN Newton MD Green M De Veij P Vandenabeele D Pizzanelli M Mayxay A Dondorp F Fernandez, Am J Trop Med Hyg 2006 75 804 811 17123969
13. Fake antimalaria drugs in Cambodia. J Rozendaal, Lancet 2001 357 890 10.1016/S0140-6736(05)71830-4 11265991
14. Counterfeit Drug Sales in Africa Strong, Threaten Public Health. P Tran, VOA News http://www.voanews.com/english/2007-10-19-voa8.cfm Accessed: 01.11.2007.
15. Antimalarial drug resistance and the importance of drug quality monitoring. MD Green, J Postgrad Med 2006 52 288 290 17102548
16. Access to antimalarial medicines improving the affordability and financing of artemisinin-based combination therapies. WHO, Malaria Control Department & Essential Drugs and Medicines Policy Department, WHO/CDS/MAL/2003.1095 2003 12 14
17. Das GPHF-Minilab - Schutz vor gefälschten und qualitativ minderwertigen Arzneimitteln. http://www.gphf.org/web/de/minilab/index.htm Accessed: 26.04.2007
18. Couterfeit Medicines and the GPHF-Minilab for Rapid Drug Quality Verification. R Jähnke, Pharm Ind 2004 66 1187 1193
19. Counterfeit Medicines. IFPMA, International Federation of Pharmaceutical Manufactures Association 2007 http://www.ifpma.org/issues/ Accessed: 17.04.2007.
20. Low-cost quality assurance of medicines using the GPHF-Minilab. R Jähnke G Küsters, Drug Inf J 2001 35 941 945
21. The hunt for counterfeit medicines. R Mukhopadhyay, Anal Chem 2007 2623 2627
22. Effect of zinc supplementation on malaria morbidity among West African children: a randomized double-blind placebo-controlled trial. O Müller H Becher A van Zweeden Baltussen Y Yé DA Diallo AT Konaté A Gbangou B Kouyaté M Garenne, BMJ 2001 322 1567 1572 11431296 10.1136/bmj.322. 7302.1567
23. Les médicaments de la rue à Niamey: Modalités de vente et contrôle de qualité de quelques médicaments anti-infectieux. AI Hamani, Université de Bamako, Faculté de Medecine de Pharmacie et d'Odonto-stomatologie Masters thesis 2005
24. 2.9.1 Zerfallszeit von Tabletten und Kapseln. Europäisches Arzneibuch, 5.0 2005 1 283 4
25. 2.2.25 UV-Vis-Spektroskopie. Arzneibuch Europäisches, 5.0 2005 1 46 8
26. Quality evaluation of chloroquine, quinine, sulfadoxine-pyrimethamine and proguanil formulations sold on the market in East Congo DR. MA Atemnkeng B Chimanuka J Plaizier-Vercammen, J Clin Pharm Ther 2007 32 123 132 10.1111/j.1365-2710.2007.00797.x 17381662
27. Antimalarial drug quality in Africa. AA Amin GO Kokwaro, J Clin Pharm Ther 2007 32 429 440 17875107
28. Chloroquine in the Ugandan market fails quality test: a pharmacovigilance study. JW Ogwal-Okeng E Owino C Obua, Afr Health Sci 2003 3 2 6 12789081
29. La détection des médicaments contrefaits par investigation de leur authenticité. Étude pilote sur le marché pharmaceutique illicite de Cote d'Ivoire. C Legris, Université Henri Poincaré, Nancy I France; Phd Thesis 2005
30. Medicines informal market in Congo, Burundi and Angola: counterfeit and sub-standard antimalarials. MC Gaudiano A Di Maggio E Cocchieri E Antoniella P Bertocchi S Alimonti L Valvo, Malar J 2007 6 22 17316432 10.1186/1475-2875-6-22
31. Evaluation of the quality of amodiaquine and sulfadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania. OM Minzi MJ Moshi D Hipolite AY Massele G Tomson O Ericsson LL Gustafsson, J Clin Pharm Ther 2003 28 117 122 10.1046/j.1365-2710.2003.00470.x 12713608
32. Assessment of the incidence of substandard drugs in developing countries. O Shakoor RB Taylor RH Behrens, Trop Med Int Health 1997 2 839 884 10.1046/j.1365-3156.1997.d01-403.x 9315042
33. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. RB Taylor O Shakoor RH Behrens M Everard AS Low J Wangboonskul RG Reid JA Kolawole, Lancet 2001 357 1933 1936 10.1016/S0140-6736(00)05065-0 11425415
34. The quality of antimalarials. A study in selected African countries. WHO, Geneva: World Health Organization 2003 1 67
35. The quality of sulphadoxine-pyrimethamine and amodiaquine products in the Kenyan retail sector. AA Amin RW Snow GO Kokwaro, J Clin Pharm Ther 2005 30 559 65 10.1111/j.1365-2710.2005.00685.x 16336288
36. Counterfeit and substandard antimicrobial drugs: a review of the scientific evidence. T Kelesidis I Kelesides PI Rafailidis ME Falagas, J Antimicrob Chemother 2007 60 2 214 236 10.1093/jac/dkm109 17550892
37. In vitro evaluation of the quality of essential drugs on the Tanzanian market. PG Risha D Shewiyo A Msami G Masuki G Vergote C Vervaet JP Remon, Trop Med Int Health 2002 7 701 707 10.1046/j.1365-3156.2002.00937.x 12167097
38. Manslaughter by fake artesunate in Asia - Will Africa be next. PN Newton R Mc Gready F Fernandez MD Green M Sunjio C Bruneton S Phanouvong P Millet CJM Whitty AO Talisuna S Proux EM Christophel G Malenga P Singhasivanon K Bojang H Kaur K Palmer NPJ Day BM Greenwood F Nosten NJ White, PLos Med 2006 3 e197 16752952 10.1371/journal.pmed.0030197
39. Quality control of active ingredients in artemisinin-derivative- antimalarials within Kenya and DR Congo. MA Atemnkeng K De Cock J Plaizier-Vercammen, Trop Med Int Health 2007 12 68 74 17207150